Volume 19, Issue 2 (Summer & Autumn 2022)                   ASJ 2022, 19(2): 111-118 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ahrabi B, Noroozian M, Taheri-Panah R, Nazarian H, Fadaee Fathabadi F, Alaee S, et al . Effect of Adriamycin on α1β1, α1β4, and ανβ3 Expression in Rat Endometrium in Estrus Phase. ASJ 2022; 19 (2) :111-118
URL: http://anatomyjournal.ir/article-1-588-en.html
1- Infertility and Reproductive Health Research Center (IRHRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Department of Reproductive Biology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
4- Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (1319 Views)
Introduction: Although the effect of adriamycin, a chemical drug used to treat cancer, is known to affect gametogenesis and ovarian function, the drug’s effect on endometrial receptivity and expression of integrin genes is unclear. To fill this gap, we aimed to investigate the effect of adriamycin on the expression of integrin genes that play a role in endometrial receptivity.
Methods: A total of 32 female rats weighing about 200 g were tested in the present study. The rats were divided into 4 groups: Healthy (sham), control, and experimental, with adriamycin at 4 mg/kg and 8 mg/kg doses for 6 weeks. Two weeks after the injection of adriamycin at an 8 mg/kg dose in the treatment group, all rats were sacrificed, but the treatment group with a 4 mg/kg dose of adriamycin continued the treatment. Then, the estrus phase was determined in the three groups using vaginal smears. The endometrial tissue was removed, and gene expression levels of α1β1, α1β4, and ανβ3 genes were evaluated using real-time PCR methods in the three groups.
Results: The rats’ weight decreased significantly in the treatment group with adriamycin. The process of weight loss was found to be dose-dependent. Integrin gene expression in the adriamycin group in the estrus phase had no significant difference compared with that in the control and sham groups (P>0.05). In the adriamycin group, the expression of integrin α1 (intgα1) increased significantly (P<0.05; P=0.013).
Conclusion: The expression of integrin genes did not change, except for integrin alpha1, during the estrus phase in the endometrium treated with adriamycin drug. Probably, adriamycin did not have any effect on the expression of integrin genes.
Full-Text [PDF 703 kb]   (122 Downloads) |   |   Full-Text (HTML)  (61 Views)  
Type of Study: Original | Subject: Reproductive Biology
Received: 2022/03/10 | Accepted: 2022/05/15 | Published: 2022/07/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.